1. Georges H. Mairesse, Patrick Moran, Isabelle C. Van Gelder, Christian Elsner (Germany), Marten Rosenqvist5 (Sweden), Jonathan Mant et al. Screening for atrial fibrillation: a European Heart RhythmAssociation (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and SociedadLatinoamericana de Estimulación Cardiaca y Electrofisiología (SOLAECE).
2. Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, et al. Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS. Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la fibrilación auricular
3. Taggar JS, Coleman T, Lewis S, Heneghan C, Jones M. Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: a systematic review and meta-analysis. Eur J Prev Cardiol 2016;23:1330–8.
4. Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? J R C Physicians Edinb 2012;42(Suppl 18):5–22.
5. Wiesel J, Wiesel D, Suri R, Messineo FC. The Use of a Modified Sphygmomanometer to Detect Atrial Fibrillation in Outpatients. Pacing Clin Electrophysiol 2004;27:639–43.
6. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-51.
7. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke Wet al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011 Sep 8;365(10):883-91
8. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M,et al. Apixaban versus warfarin in patients with atrial fibrillation.N Engl J Med. 2011 Sep 15;365(11):981-92.
